{
    "2019-01-03": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Sprycel",
                        "FDA",
                        "label expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Verily lines up $1 billion investment",
                "features": {
                    "keywords": [
                        "Verily",
                        "investment",
                        "billion"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-20",
                "original_text": "Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "momentum",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "Ironwood/Allergan Settle Linzess Patent Litigation With Mylan",
                "features": {
                    "keywords": [
                        "Ironwood",
                        "Allergan",
                        "Linzess",
                        "patent litigation",
                        "Mylan"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}